TriangleFOR PATIENTS · SOURCE READING
Treatment of Recurrent or Progressive Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)
Source: Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 7, 2022 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of pancreatic neuroendocrine tumors (NETs) that continue to grow during treatment or recur (come back) may include the following:
Source links and citations
Chemotherapy.
Source links and citations
Hormone therapy.
Source links and citations
Targeted therapy.
Source links and citations
For liver metastases:
Source links and citations
For liver metastases:
Hepatic arterial occlusion or chemoembolization, with or without systemic chemotherapy.
Source links and citations
A clinical trial of a new therapy.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice